| Financial Year |
March 31 2023 |
| Monetary Funds |
6,334,482,455.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,275,813,684.13 |
| Advances to Suppliers |
597,726,105.10 |
| Other Receivables |
100,429,058.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
242,315.19 |
| Inventories |
5,185,526,592.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
524,267.64 |
| Other Current Assets |
636,778,814.64 |
| Total Current Assets |
16,381,514,156.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,489,636,168.44 |
| Investment Properties |
-- |
| Fixed Assetes |
2,159,497,765.22 |
| Under-construction Projects |
326,037,367.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,545,032,870.37 |
| R&D expenses |
1,935,718,551.86 |
| Goodwill |
72,847,213.45 |
| Long-Term Deferred and Prepaid Expenses |
37,669,006.98 |
| Deferred Income Tax Assets |
163,113,826.26 |
| Other Non-Current Assets |
2,131,410,091.56 |
| Sub-Total of Non-Current Assets |
14,894,082,038.02 |
| Total Assets |
31,275,596,194.15 |
| Short-Term Loans |
337,611,946.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
390,000,000.00 |
| Accounts Payable |
1,665,303,567.58 |
| Accounts Received In Advance |
4,000,967.00 |
| Employee Compensation Payable |
12,449,356.43 |
| Taxes Payable |
83,761,174.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
209,630,880.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
346,909,954.44 |
| Other Current Liabilities |
13,666,302.81 |
| Sub-Total of Current Liabilities |
5,017,610,533.14 |
| Long-term Loans |
1,757,982,380.87 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,061,742,371.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
64,600,882.72 |
| Deferred Income Tax Liabilities |
28,265,387.72 |
| Other Non-Current Liabilities |
573,577,450.05 |
| Sub-Total of Non-Current Liabilities |
8,336,211,662.42 |
| Total Liabilities |
13,353,822,195.56 |
| Paid-In Capital(Or Share Stock) |
1,464,013,974.00 |
| Capital Surplus |
11,034,366,147.72 |
| Surplus Reserve |
352,991,842.42 |
| LESS:Treasury Stock |
191,397,950.00 |
| Undistributed Profits |
4,509,813,159.74 |
| Minority Stockholder's Interest |
744,571,788.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,177,202,210.17 |
| Owner's Equity（Stockholder's Equity） |
17,921,773,998.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,275,596,194.15 |
